Efficacy and safety of dalbavancin as suppressive therapy Accéder au pdf ► Beringheli TDupieux-Chabert Cgoutelle Sroussel-gaillard TDhelens CRascle PDoudet CRoux Sjavaux CTriffault-Fillit Cbraun EFerry Tvalour FLyon BJI Study Group Posters 43th Annual Meeting of the European Bone and Joint Infection Society (EBJIS) 2025 Dalbavancinsuppressive therapy